Inizio Ignite

FPS Food and Pharma Systems Announces Production Plant Expansions

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Integrated Health Risk Assessment in Food and Pharma Sectors

Integrated health risk assessment in food and pharma sectors aligns toxicology, exposure modeling, and regulatory standards to address cumulative chemical risks across daily consumption and therapy. By harmonizing methodologies and leveraging shared data, regulators and manufacturers can build a more holistic, science-driven safety framework that protects long-term public health.

Advanced Analytical Technologies in Pharma Impurity Testing

Advanced analytical technologies in pharma impurity testing are transforming how trace contaminants are detected, identified, and controlled across the drug lifecycle. With high-resolution instrumentation, automation, and AI-driven insights, the industry is strengthening precision, data integrity, and patient safety to meet increasingly stringent purity standards.

Managing PFAS Regulations in Pharmaceutical Supply Chains

PFAS regulations in pharmaceutical supply chains are reshaping how critical materials are sourced, validated, and justified amid rising environmental scrutiny. Manufacturers must balance sustainability, regulatory compliance, and material performance to ensure uninterrupted delivery of safe and effective medicines.
- Advertisement -

FPS Food and Pharma Systems has announced it is expanding its production plant in Fiorenzuola d’Arda for greater flexibility and timeliness on production systems.

A leading company in design, manufacture, and installation of fine size reduction machines for micronising and containment solutions for sterile and/or highly potent active pharmaceutical ingredients (API), FPS Food and Pharma Systems has disclosed the beginning of the plant’s enlargement in Fiorenzuola d’Arda.

The expansion is designed to improve the production process management and allow a significant increase in production capacity.

Adjacent to the current facility, the new area is composed of approximately 3000m2 covered and 3000m2 uncovered land, which will be dedicated to the assembly and testing of FPS’ systems. A further area will be dedicated to the assembly execution and storage of mock-up.

An equipped cafeteria and training classroom will also be available soon, with technical workshops planned for 2017.

The venue was recently enlarged and modernised with the construction of a new offices area and a research and development (R&D) test centre. The facilities’ redesigns help it adapt to the company’s needs.

FPS Food and Pharma Services’ vice-president and technical manager Carlo Corsini said: “It’s been months since the inauguration of the new area dedicated to the R&D and Test Center but, the steady development, has made necessary to plan, in few time, new works programed with foresight and carried out with determination in order to strengthen the logistics structure.”

 The company’s president Giovanni Gianola added: “With the increase of production capacity of the site of Fiorenzuola d’Arda Plant, FPS renews its commitment to the improvement and development of micronisation and fine grinding systems, as well as containment solutions.

“We are proud of Italian excellence; we can confirm the current employment level and to show to our territory the new factory, which will allow us to be even more competitive for the benefit of our customers.”

Latest stories

Related stories

Integrated Health Risk Assessment in Food and Pharma Sectors

Integrated health risk assessment in food and pharma sectors aligns toxicology, exposure modeling, and regulatory standards to address cumulative chemical risks across daily consumption and therapy. By harmonizing methodologies and leveraging shared data, regulators and manufacturers can build a more holistic, science-driven safety framework that protects long-term public health.

Advanced Analytical Technologies in Pharma Impurity Testing

Advanced analytical technologies in pharma impurity testing are transforming how trace contaminants are detected, identified, and controlled across the drug lifecycle. With high-resolution instrumentation, automation, and AI-driven insights, the industry is strengthening precision, data integrity, and patient safety to meet increasingly stringent purity standards.

Managing PFAS Regulations in Pharmaceutical Supply Chains

PFAS regulations in pharmaceutical supply chains are reshaping how critical materials are sourced, validated, and justified amid rising environmental scrutiny. Manufacturers must balance sustainability, regulatory compliance, and material performance to ensure uninterrupted delivery of safe and effective medicines.

Nitrosamine Risk Mitigation in Global Pharma Manufacturing

Nitrosamine risk mitigation in global pharma manufacturing requires proactive control of chemical pathways, excipients, and operational practices to prevent trace-level carcinogenic impurities. Advanced analytics, rigorous risk assessments, and strengthened GMP frameworks are now essential to ensure long-term product safety and regulatory compliance.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »